You are here

  • Home
  • Archive
  • Volume 22, Issue 5
  • Quality of reporting of harms in randomised controlled trials of pharmacological interventions for rheumatoid arthritis: a systematic review

Article info

Article menu
Download PDFPDF
Evidence synthesis
General medicine
Quality of reporting of harms in randomised controlled trials of pharmacological interventions for rheumatoid arthritis: a systematic review

Authors

  1. Correspondence to Dr Muhammad Abdul Hadi, Leicester School of Pharmacy, De Montfort University, Hawthorn Building, Leicester LE1 9BH, UK; muhammad.hadi{at}dmu.ac.uk, abdulhadi83{at}gmail.com

Citation

Hadi MA, McHugh GA, Conaghan PG
Quality of reporting of harms in randomised controlled trials of pharmacological interventions for rheumatoid arthritis: a systematic review
BMJ Evidence-Based Medicine 2017;22:170-177.

Publication history

  • Accepted August 21, 2017
  • First published September 2, 2017.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.